Iovance Biotherapeutics, Inc. (IOVA) revenue

Revenue · fiscal 2025
$263.50M

Iovance Biotherapeutics, Inc. (IOVA) reported revenue of $263.50M in fiscal 2025 (the year ended December 31, 2025). That is 60.6% higher than the $164.07M of fiscal 2024. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$263.50M
Change on fiscal 2024
+60.6%
Highest on record
$263.50Mfiscal 2025
Lowest on record
$1.19Mfiscal 2023
Fiscal years on record
32023–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Iovance Biotherapeutics, Inc. revenue, in more detail

Across the 3 fiscal years on record (2023–2025), the highest was $263.50M in fiscal 2025 and the lowest $1.19M in fiscal 2023.

History · 3 fiscal years

Revenue by fiscal year

Iovance Biotherapeutics, Inc. revenue, year by year

Iovance Biotherapeutics, Inc. (IOVA) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$263.50M 60.6% up
2024$164.07M 13,699.0% up
2023$1.19M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on IOVA

Iovance Biotherapeutics, Inc., figure by figure

Iovance Biotherapeutics, Inc. (IOVA) overview: price, valuation and scorecard

Iovance Biotherapeutics, Inc. revenue: questions and answers

What is Iovance Biotherapeutics, Inc.'s revenue?

Iovance Biotherapeutics, Inc. (IOVA) reported revenue of $263.50M in fiscal 2025 (the year ended December 31, 2025). That is 60.6% higher than the $164.07M of fiscal 2024.

What are the highest and lowest revenue figures on record for Iovance Biotherapeutics, Inc.?

Across the 3 fiscal years on record (2023–2025), the highest was $263.50M in fiscal 2025 and the lowest $1.19M in fiscal 2023.

How is Iovance Biotherapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Iovance Biotherapeutics, Inc. it is on record here for 3 fiscal years, 2023 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Iovance Biotherapeutics, Inc. (IOVA) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/IOVA/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.